Osage University GP III LLC 13D/13G Filings for Landos Biopharma, Inc. (LABP)

Osage University GP III LLC 13D and 13G filings for Landos Biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-03
4:49 pm
Purchase		 2021-12-31 13G Landos Biopharma, Inc.
LABP		 Osage University GP III LLC 182,748
4.500%		 182,748increase
(New Position)		 Filing